Clinical trial Recruiting at 1 site Interventional Ages 12 and up

Timed cerebellar stimulation with immersive virtual reality to boost social prediction

Official title: Spatiotemporal Entrainment as Innovative Neuromodulation Targeting Cerebello-cerebral Circuits for Enhancing Rehabilitation Outcomes of Cognitive and Social Skills in Progressive and Acquired Cerebellar Diseases

Run by LIFE - Research and Care Institute - Santa Lucia IRCCS · NCT07500103 · Data updated 2026-11-12

This trial will try personalized cerebellar HD-tACS together with immersive virtual reality to improve social prediction in adolescents and young adults with congenital cerebellar malformations and in adults with degenerative cerebellar atrophy.

Quick facts

Study typeInterventional
Ages12 Years and up
SexAll
Enrollment60 (estimated)
SponsorLIFE - Research and Care Institute - Santa Lucia IRCCS
Academic / other
Locations2 sites (Pavia and 1 other locations)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedFebruary 2027
Study endsApril 2027
Registry record updatedMarch 30, 2026
Trial IDNCT07500103 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 12–32 with congenital cerebellar malformations (IQ ≥50) or adults with degenerative cerebellar atrophy (IQ ≥75) who have predominantly cerebellar damage, intact enough motor/visual function to perform the tasks, and no contraindications to tACS.

Probably not a fit

Patients with extra-cerebellar lesions, severe motor or visual impairments, diagnosed autism or other neurodevelopmental/psychiatric conditions that would prevent task participation, or any contraindication to tACS are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, sham-controlled trial run in two clinical cohorts (30 patients with congenital cerebellar malformations and 30 with degenerative cerebellar atrophy). Participants receive eight consecutive daily 1-hour immersive virtual reality sessions targeting social prediction while simultaneously receiving either EEG-guided active High-Definition transcranial Alternating Current Stimulation (HD-tACS) to the cerebellum or sham stimulation. Allocation is 1:1 active versus sham using computer-generated blocked randomization with blinding of participants and assessors. Outcomes are measured at baseline, immediately after the 8-day intervention, and at a two-month follow-up to examine short- and medium-term effects.

Why it matters

Potential benefit: If successful, the approach could improve patients' ability to anticipate others' intentions and enhance everyday social interactions.

How similar studies have gone: Small prior studies suggest cerebellar neuromodulation and virtual-reality training can alter networks and improve some cognitive functions, but the combined EEG-guided HD-tACS plus immersive social VR approach in cerebellar patients is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for patients with cerebellar malformation include:

* Documented malformations confined to the cerebellum confirmed by a 3T brain MRI scan;
* Age ranging from 12 to 32 years old;
* IQ \>= 50;
* Absence of extra-cerebellar malformations on conventional brain MRI scan.

Inclusion Criteria for patients with degenerative cerebellar atrophy include:

* Evidence of diffuse cerebellar atrophy;
* More than 6 months of illness;
* IQ \>=75;
* Absence of any cortical lesion on conventional brain MRI scans

Exclusion Criteria for both groups include:

* Presence of severe motor and visual impairments, as well as neurodevelopmental (i.e., autism), neurological or psychiatric disorders that could interfere with task execution and protocol compliance;
* Presence of any contraindication for tACS.

Where it's running

  • IRCCS National Neurological Institute "C. Mondino" Foundation
    Pavia, Italy
    Recruiting
  • I.R.C.C.S. Fondazione Santa Lucia
    Roma, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.